The PRISM (Post-Licensure Rapid Immunization Safety Monitoring) System for H1N1 Vaccine Richard...
-
Upload
abraham-johns -
Category
Documents
-
view
212 -
download
0
Transcript of The PRISM (Post-Licensure Rapid Immunization Safety Monitoring) System for H1N1 Vaccine Richard...
The PRISM (Post-Licensure Rapid Immunization Safety Monitoring)
System for H1N1 Vaccine
Richard Platt, MD, MSDepartment of Population Medicine
Harvard Pilgrim Health Care and Harvard Medical School
November 18, 2009
Aims
Conduct real-time and end-of-season analyses of:
– Pre-specified outcomes, e.g., Guillain-Barré Syndrome
– New unanticipated outcomes if concerns arise
Special Issues in H1N1 vaccine
• Need for large base population for active surveillance → health plans
• Many H1N1 vaccine doses may be given by public providers and not captured in health plan data → link to state immunization registries
Role of PRISM
• Assess large populations
– Effectively monitor Guillain-Barré syndrome and other rare events
– Shorten time to identifying problems
• Evaluate H1N1 vaccine doses given by both public and private providers
PRISM – Current season surveillance
All current health plan members
State Immunization
Registries
National Health Plans
H1N1 vaccine
exposure data
Outcome data
PRISM – Historical comparison data
Health plan members
since 2005
National Health Plans
Seasonal influenza vaccine
exposure data
Outcome data
Organizations in PRISM
Public Health Informatics Institute
HHS
StateImmunization
RegistriesHealth plans
Computer Sciences Corporation
(Technical support)
America’s Health Insurance Plans(Administration)
Harvard Dept of Population Medicine
(Scientific coordination)
Health Plans
• Selection criteria– Ability to rapidly assemble data– Ability to update data every 1-2 weeks
• Participating health plans– Aetna, CIGNA, Humana,
HealthCore (WellPoint plans in CA, NY, CO; BCBS in MI)
• Total ~25 million persons
State Immunization Registries
• Selection criteria– Timely H1N1 vaccine data– Experience matching data with health plans– Size
• Participating states– MI, FL, GA, PA, AZ, WI, MN, NY, NYC
• Total ~14 million persons in the participating health plans
Collaborators – Partial List• National Vaccine Program Office
– Daniel Salmon– Kirsten Vannice
• Centers for Disease Control and Prevention– Frank deStefano
• Food and Drug Administration– Robert Ball
• America's Health Insurance Plans
– Kevin Fahey– Barbara Lardy– Victor Rhee
• Public Health Informatics Institute
– Ellen Wild– Bill Brand– Elaine Lowery– Therese Hoyle– Alan Hinman– David Ross
• Harvard Pilgrim Health Care Institute
– Richard Platt– Tracy Lieu– Grace Lee– Jeff Brown– Melisa Rett– Charlene Gay– Katherine Yih– Yury Vilk
• Health Information Systems Consulting – Robert Rosofsky
• EpiPatterns– Yinong Young-Xu
• Computer Sciences Corporation
– Daniel Foltz– Jim Van Dyke– Aurelia Ford– Jim Roddy– John Manson– Vic Tandon
• Cigna– Therese Conner– Anthony Sumner– Daniel Carmody– Ha Nguyen– Mark Regine
• Aetna– Claire Spettell– Cheryl Walraven– Joaquim Fernandes– Yihai Liu
• Healthcore (Wellpoint, BC/BS)– Peter Wahl– Alex Cannon– Lori Meyers– Greg Daniel– Chris Hetrick
• Humana– David Nau– Yihau Xu– Amy Ball
• Arizona State Immunization Information System
– Lisa Rasmussen – Roger Volp– Richard Bradley
• Florida Shots– Susan Lincicome– Pete Garner
• Georgia Registry of Immunization Transactions and Services
– Tracy Culbreath
– Elizabeth Sullivan
– Michelle Conner
– Archie Banks
– Andre Wilson
• Michigan Care Improvement Registry
– Therese Hoyle
– Ian Hancke
• Minnesota Immunization Information Connection
– Emily Peterson
– Diana Jaeger
• New York State Immunization Information System
– Loretta Santilli
• New York City, Citywide Immunization Registry
– Vikki Papadouka
– Rezaul Kabir
– Luiz Homem de Mello
• Pennsylvania Statewide Immunization Information System
– Frank Caniglia
– Mike Jamula
• Wisconsin Immunization Registry– Dan Hopfensperger
Data Sharing and Confidentiality
• Classified as public health practice, not research
• Health plans and states encouraged to use the HIPAA public health exemption for exchange of Protected Health Information
• All person-level data remains at the health plans after transformation to standard format
• Distributed programs create counts that are shared with scientific coordinating center
Maintaining Confidentiality
Health Plananalysts
Person-level data (with merged registry immunization data)
Counts of immunizations and outcomes
Standard programs
Harvard andCSC analysts
Reports and analyses
Health plan firewall
Outcomes Being Monitored
• Guillain-Barré Syndrome (GBS)
• Central nervous system demyelinating diseases
• Neuropathies
• Seizures
• Encephalitis
• Bell’s palsy
• Myocarditis
• Ataxia
• Anaphylaxis
• Spontaneous abortion
• Pre-eclampsia
Weekly Monitoring of Counts
• Risk (exposure) windows– Periods after H1N1 vaccination– 14, 21, or 42 days, depending on
outcome
• Comparisons – Expected counts based on historical
rates after seasonal influenza vaccination
– Unexposed time periods in same persons
Statistical Analyses
• Weekly analyses of cumulative data
• Repeated testing of the same data increases the chance of false-positive results
• Adjust for this using maximized sequential probability ratio testing (maxSPRT)
Statistical Methods for Comparisons
• Expected counts based on historical rates – Poisson maxSPRT
• Unexposed time periods in same persons– Self-controlled case series analysis using
binomial maxSPRT
Signal Evaluation• Preliminary findings of increased risk will need
further evaluation
• Computerized data– Stratified analyses– Temporal scan – Logistic regression
• Chart review, if needed– Confirm or exclude cases as true– Gather data on potential confounders and other
variables
PRISM – Current Challenges
• Timeline – Processes for data sharing between
health plans and state immunization registries
– Programming and coordination
• Data latency
Implications for Vaccine SafetyPRISM is enhancing:
• Framing of vaccine safety surveillance as a public health activity
• Creation of public-private collaborations for public health
• Implementation of methods for rapid analysis of data that remains in possession of covered entities
• Development of methods for responding to findings